All Stories

  1. Angiotensin Converting Enzyme Inhibition and Mortality in Pulmonary Hypertension Associated With Chronic Obstructive Pulmonary Disease (PH‐COPD)
  2. Sotatercept Rescue Therapy for Acute Right Heart Failure in HIV‐Associated PAH
  3. PVRI ‐ GoDeep —A Global Meta‐Registry at the Crossroads of Heart and Lung
  4. Respiratorische Erkrankungen
  5. Male survival disadvantage in pulmonary hypertension: independent of aetiology, age, disease severity, comorbidities and treatment
  6. Multi-beat right ventricular–pulmonary arterial coupling and survival in pulmonary hypertension: are we missing the right signals?
  7. Acute Hemodynamic Effects of Sotatercept
  8. TAPSE/sPAP Ratio to Improve Risk Assessment in Pulmonary Arterial Hypertension
  9. Risikostratifizierung und Behandlungsziele bei pulmonalarterieller Hypertonie
  10. Pulmonale Hypertonie assoziiert mit Lungenerkrankungen
  11. Dual Impacts of Lung Transplantation on the Recovery and Comorbidity of Interstitial Lung Diseases: A Longitudinal Assessment of the Benefits and Burden
  12. Increase in Alveolar Septal Width Is a Histological Predictor of Chronic Lung Allograft Dysfunction and Survival in Lung Transplant Recipients—A Longitudinal Study
  13. Method for generating right ventricular pressure-volume loops in routine practice
  14. Hemodynamics and Phosphodiesterase-5 Inhibitor Treatment Associated with Survival in ILD-PH: A PVRI GoDeep Meta-Registry Analysis
  15. Exercise Haemodynamics in Pulmonary Hypertension – a Prospective Pressure–Volume Loop Study on Right Ventricular Adaptation and Prognosis
  16. Echocardiographic Measure of Right Ventricular–Pulmonary Arterial Coupling Predicts Survival in Lung Cancer
  17. Right-sided heart failure in acute respiratory distress syndrome
  18. Survival Outcomes and Impact of Targeted PAH Therapy in Portopulmonary Hypertension in the PVRI GoDeep Meta‐Registry
  19. A simple electrocardiographic model for an improved detection of chronic thromboembolic pulmonary hypertension after pulmonary embolism
  20. Automated CT Image Processing for the Diagnosis, Prediction, and Differentiation of Phenotypes in Chronic Lung Allograft Dysfunction After Lung Transplantation
  21. Loss of right ventricular outflow function in pulmonary hypertension
  22. Association of Phosphodiesterase-5 Inhibitor Treatment With Improved Survival in Pulmonary Hypertension Associated With COPD in the Pulmonary Vascular Research Institute GoDeep Meta-Registry
  23. Exercise Limitation in Pulmonary Hypertension – Physiological Insights into the 6-Minute Walk Test
  24. The Diagnostic Accuracy of an Electrocardiogram in Pulmonary Hypertension and the Role of “R V1, V2 + S I, aVL − S V1”
  25. SPARCL1 and NT-proBNP as Biomarkers of Right Ventricular-to-Pulmonary Artery Uncoupling in Pulmonary Hypertension
  26. Right ventricular–pulmonary arterial coupling predicts mortality in precapillary pulmonary hypertension
  27. Association of PH-Targeted Therapy and Survival in Precapillary PH with mPAP between 21 and 24 mmHg
  28. Comparison of Contemporary Risk Scores in All Groups of Pulmonary Hypertension
  29. Native hepatic T1-time as a non-invasive predictor of diastolic dysfunction and a monitoring tool for disease progression and treatment response in patients with pulmonary hypertension
  30. Air travel in patients suffering from pulmonary hypertension—A prospective, multicentre study
  31. Liver stiffness is associated with right heart dysfunction, cardiohepatic syndrome, and prognosis in pulmonary hypertension
  32. Right ventricular pressure-strain relationship-derived myocardial work reflects contractility: Validation with invasive pressure-volume analysis
  33. Physiological mechanisms behind respiratory variations in right atrial pressure in pulmonary hypertension
  34. Precision Cardiac Monitoring: Algorithmic Real-Time Assessment of Right Ventricular Function in Pulmonary Hypertension
  35. A Novel Rat Model of Mild Pulmonary Hypertension Associated with Pulmonary Venous Congestion Induced by Left Pulmonary Vein Banding
  36. Clinical and functional relevance of right ventricular contraction patterns in pulmonary hypertension
  37. Die neue Definition und Klassifikation der pulmonalen Hypertonie
  38. Diagnose Algorithmus der pulmonalen Hypertonie und Screening-Verfahren
  39. Pulmonale Hypertonie assoziiert mit Linksherzerkrankungen (Gruppe 2)
  40. Changes in Doppler‐Derived Kidney Venous Flow and Adverse Cardiorenal Outcomes in Patients With Heart Failure
  41. Hepatorenal dysfunction in patients with chronic thromboembolic pulmonary hypertension
  42. Echocardiographic evaluation of right ventricular diastolic function in pulmonary hypertension
  43. Echocardiographic Pressure–Strain Loop-Derived Stroke Work of the Right Ventricle: Validation Against the Gold Standard
  44. Estimated plasma volume status: association with congestion, cardiorenal syndrome and prognosis in precapillary pulmonary hypertension
  45. Erratum to: Right ventricular failure in pulmonary hypertension: recent insights from experimental models
  46. Right ventricular failure in pulmonary hypertension: recent insights from experimental models
  47. Adaptive Versus Maladaptive Right Ventricular Remodelling
  48. Risk assessment in pulmonary hypertension based on routinely measured laboratory parameters
  49. Relevance of Cor Pulmonale in COPD With and Without Pulmonary Hypertension: A Retrospective Cohort Study
  50. Clinical Relevance of Right Atrial Functional Response to Treatment in Pulmonary Arterial Hypertension
  51. The C0-C1f Region of Cardiac Myosin Binding Protein-C Induces Pro-Inflammatory Responses in Fibroblasts via TLR4 Signaling
  52. Right ventricular pressure-volume loop shape and systolic pressure change in pulmonary hypertension
  53. Validity of echocardiographic tricuspid regurgitation gradient to screen for new definition of pulmonary hypertension
  54. Reply to “Risk stratification in PH associated with interstitial lung disease: The Holy Grail?”
  55. A novel non-invasive and echocardiography-derived method for quantification of right ventricular pressure–volume loops
  56. Pulmonary complications of tyrosine kinase inhibitors in myeloproliferative disorders
  57. Advanced risk stratification of intermediate risk group in pulmonary arterial hypertension
  58. Risk assessment in severe pulmonary hypertension due to interstitial lung disease
  59. Sex Differences in Right Ventricular–Pulmonary Arterial Coupling in Pulmonary Arterial Hypertension
  60. Impact of timing on right heart catheterization measurements in pulmonary hypertension
  61. Gamma-Glutamyltransferase in pulmonary hypertension: A reliable biomarker?
  62. Reliability of echo systolic pulmonary arterial pressure to detect new definition of pulmonary hypertension
  63. Risk assessment in severe pulmonary hypertension due to interstitial lung disease
  64. In-depth risk stratification in pulmonary arterial hypertension
  65. Impact of SARS-CoV-2 pandemic on pulmonary hypertension out-patient clinics in Germany: a multi-centre study
  66. Evaluation of pulmonary hypertension by right heart catheterisation: does timing matter?
  67. P4764Development of a qualitative and quantitative detection method for the N-terminal fragment of cardiac myosin-binding protein C